Acute Myeloid Leukaemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
New research program receives DKK 100 million in funding from Novo Nordisk Foundation

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

FDA approves fixed dose combination chemotherapy for subtypes of AML that have poor survival outcomes

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Prolonged use of cancer inhibitors can lead to severe cardiovascular problems

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists find way to improve anti-cancer effect of Smac-mimetic drugs

Scientists find way to improve anti-cancer effect of Smac-mimetic drugs

Study shows how different genetic mutations cause acute myeloid leukemia

Study shows how different genetic mutations cause acute myeloid leukemia

New technology could hold key to predicting outcome of blood cancer patients

New technology could hold key to predicting outcome of blood cancer patients

Global inequalities in survival for childhood leukemia still persist in some countries, study finds

Global inequalities in survival for childhood leukemia still persist in some countries, study finds

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Knowledge bank approach could help find best treatment option for AML patients

Knowledge bank approach could help find best treatment option for AML patients

OGT introduces three new Cytocell Aquarius FISH probes

OGT introduces three new Cytocell Aquarius FISH probes

ATR inhibitors show improved survival and effectiveness in animal models of cancer

ATR inhibitors show improved survival and effectiveness in animal models of cancer

Adolescents and young adults have lower cancer survival rates compared to children

Adolescents and young adults have lower cancer survival rates compared to children

Mitoxantrone for MS linked to colorectal cancer risk

Mitoxantrone for MS linked to colorectal cancer risk

Researchers uncover new clue that may help fight AML

Researchers uncover new clue that may help fight AML

New combination treatment shows promise for treating acute myeloid leukaemia

New combination treatment shows promise for treating acute myeloid leukaemia

Discovery could lead to new leukaemia therapies

Discovery could lead to new leukaemia therapies

Simple blood test could predict relapse in AML patients

Simple blood test could predict relapse in AML patients

Hhex protein could be key target for new therapies to cure leukaemia

Hhex protein could be key target for new therapies to cure leukaemia

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML